关注
Devan V. Mehrotra
Devan V. Mehrotra
在 merck.com 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
SP Buchbinder, DV Mehrotra, A Duerr, DW Fitzgerald, R Mogg, D Li, ...
The Lancet 372 (9653), 1881-1893, 2008
20122008
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
MJ McElrath, SC De Rosa, Z Moodie, S Dubey, L Kierstead, H Janes, ...
The Lancet 372 (9653), 1894-1905, 2008
8782008
Safety and Immunogenicity of a Replication-Incompetent Adenovirus Type 5 HIV-1 Clade B gag/pol/nef Vaccine in Healthy Adults
FH Priddy, D Brown, J Kublin, K Monahan, DP Wright, J Lalezari, ...
Clinical infectious diseases 46 (11), 1769-1781, 2008
3262008
Step Study Protocol Team. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
SP Buchbinder, DV Mehrotra, A Duerr, DW Fitzgerald, R Mogg, D Li, ...
Lancet 372 (9653), 1881-1893, 2008
2822008
Should baseline be a covariate or dependent variable in analyses of change from baseline in clinical trials?
GF Liu, K Lu, R Mogg, M Mallick, DV Mehrotra
Statistics in medicine 28 (20), 2509-2530, 2009
2202009
Scientific white paper on concentration-QTc modeling
C Garnett, PL Bonate, Q Dang, G Ferber, D Huang, J Liu, D Mehrotra, ...
Journal of pharmacokinetics and pharmacodynamics 45, 383-397, 2018
1822018
Recommendations for safety planning, data collection, evaluation and reporting during drug, biologic and vaccine development: a report of the safety planning, evaluation, and …
BJ Crowe, HA Xia, JA Berlin, DJ Watson, H Shi, SL Lin, J Kuebler, ...
Clinical Trials 6 (5), 430-440, 2009
1502009
Use of the false discovery rate for evaluating clinical safety data
DV Mehrotra, JF Heyse
Statistical methods in medical research 13 (3), 227-238, 2004
1422004
A cautionary note on exact unconditional inference for a difference between two independent binomial proportions
DV Mehrotra, ISF Chan, RL Berger
Biometrics 59 (2), 441-450, 2003
1412003
AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV …
RT Schooley, J Spritzler, H Wang, MM Lederman, D Havlir, DR Kuritzkes, ...
The Journal of infectious diseases 202 (5), 705-716, 2010
1362010
Clinical endpoints for evaluating efficacy in COVID-19 vaccine trials
DV Mehrotra, HE Janes, TR Fleming, PW Annunziato, KM Neuzil, ...
Annals of internal medicine 174 (2), 221-228, 2021
1152021
Impact of herpes simplex virus type 2 on HIV-1 acquisition and progression in an HIV vaccine trial (the Step study)
RV Barnabas, JN Wasserheit, Y Huang, H Janes, R Morrow, J Fuchs, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 57 (3), 238-244, 2011
1062011
Detection of HIV vaccine-induced cell-mediated immunity in HIV-seronegative clinical trial participants using an optimized and validated enzyme-linked immunospot assay
S Dubey, J Clair, TM Fu, L Guan, R Long, R Mogg, K Anderson, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 45 (1), 20-27, 2007
1042007
Cross-reactivity of anti–HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1–positive individuals from 4 continents
PM Coplan, SB Gupta, SA Dubey, P Pitisuttithum, A Nikas, B Mbewe, ...
The Journal of infectious diseases 191 (9), 1427-1434, 2005
1032005
Enhanced rates and magnitude of immune responses detected against an HIV vaccine: effect of using an optimized process for isolating PBMC
LS Kierstead, S Dubey, B Meyer, TW Tobery, R Mogg, VR Fernandez, ...
AIDS research and human retroviruses 23 (1), 86-92, 2007
892007
An Ad5-vectored HIV-1 vaccine elicits cell-mediated immunity but does not affect disease progression in HIV-1–infected male subjects: Results from a randomized placebo …
DW Fitzgerald, H Janes, M Robertson, R Coombs, I Frank, P Gilbert, ...
Journal of Infectious Diseases 203 (6), 765-772, 2011
882011
Effects of controlled-onset extended-release verapamil on nocturnal blood pressure (dippers versus nondippers)
WB White, DV Mehrotra, HR Black, TD Fakouhi
The American journal of cardiology 80 (4), 469-474, 1997
811997
Safety and Immunogenicity of Adenovirus-Vectored Near-Consensus HIV Type 1 Clade B gag Vaccines in Healthy Adults
CD Harro, MN Robertson, MA Lally, LD O'Neill, S Edupuganti, ...
AIDS research and human retroviruses 25 (1), 103-114, 2009
802009
Estimating the benefit of an HIV-1 vaccine that reduces viral load set point
SB Gupta, LP Jacobson, JB Margolick, CR Rinaldo, JP Phair, ...
The Journal of infectious diseases 195 (4), 546-550, 2007
802007
Improving the Brown-Forsythe solution to the generalized Behrens-Fisher problem
DV Mehrotra
Communications in Statistics-Simulation and Computation 26 (3), 1139-1145, 1997
701997
系统目前无法执行此操作,请稍后再试。
文章 1–20